期刊文献+

云南省三甲医院3411株铜绿假单胞菌的耐药分析 被引量:1

Analysis on Drug Resistance of 3,411 Strains of Pseudomonas Aeruginosa in Third-class A Hospital of Yunnan Province
下载PDF
导出
摘要 目的 :分析我院铜绿假单胞菌的临床分布及耐药性,为临床合理使用抗菌药提供指导。方法 :选取我院2014年7月—2017年7月各临床科室就诊的住院和门诊患者所送检标本中分离的铜绿假单胞菌作为研究对象,分析该菌的耐药性。结果 :分离出的3 411株铜绿假单胞菌中有49.43%来自呼吸道标本,主要分布于整形烧伤科和ICU,所占比例分别为19.61%、18.21%;分离出的铜绿假单胞菌对氨苄西林耐药率为100%,对阿莫西林/克拉维酸、头孢曲松、头孢呋辛、头孢噻肟、头孢西丁、复方磺胺甲恶唑分别达到97%以上;来源于血液标本中的铜绿假单胞菌对哌拉西林、哌拉西林/他唑巴坦、头孢他啶、亚胺培南、美罗培南、阿米卡星、庆大霉素、环丙沙星、左氧氟沙星的耐药率均高于来源痰液标本中的铜绿假单胞菌,差异有统计学意义(P <0.05)。结论 :2014年7月—2017年7月我院分离出的3 411株铜绿假单胞菌中大部分来自整形烧伤外科和ICU,血液中分离出的铜绿假单胞菌对多数抗菌药物的耐药率均高于痰液中的耐药率。 Objective:To analyze the clinical distribution and drug resistance of Pseudomonas aeruginosa in our hospital to provide guidance for the clinically rational use of antimicrobials.Methods:Pseudomonas aeruginosa strains isolated from the inpatients and outpatients of the Department of Clinical Laboratory in our hospital from July 2014 to July 2017 were selected as subjects investigated,and their drug resistance was analyzed.Results:49.43%of the isolated 3,411 strains of Pseudomonas aeruginosa were from respiratory specimens,mainly distributed in the Department of Plastic Burn and ICU,accounting for 19.61%and 18.21%,respectively.The resistance rate of isolated Pseudomonas aeruginosa to ampicillin was 100%,and the resistance rates to amoxicillin/clavulanic acid,ceftriaxone,cefuroxime,cefotaxime,cefoxitin and compound sulfamethoxazole were more than 97%.The resistance rates of Pseudomonas aeruginosa from blood samples to piperacillin,piperacillin/tazobactam,ceftazidime,imipenem,meropenem,amikacin,gentamicin,ciprofloxacin and levofloxacin were higher than those from sputum samples,and the differences were statistically significant(P<0.05).Conclusion:Most of the 3,411 Pseudomonas aeruginosa strains isolated in our hospital from July 2014 to July 2017 were from the Department of Plastic Burn Surgery and ICU,and the resistance rate of Pseudomonas aeruginosa number isolated from blood to most antimicrobials was higher than that from sputum.
作者 杨璐 王青莹 王玉明 单斌 李庆蓉 Yang Lu;Wang Qing-ying;Wang Yu-ming;Shan Bin;Li Qing-rong(Department of Clinical Laboratory,the Second Affiliated Hospital of Kunming Medical University,Kunming Yunnan 650101,China)
出处 《中国合理用药探索》 CAS 2019年第9期1-3,6,共4页 Chinese Journal of Rational Drug Use
关键词 铜绿假单胞菌 耐药性 合理用药 Pseudomonas Aeruginosa Drug Resistance Rational Drug Use
  • 相关文献

参考文献6

二级参考文献27

  • 1KLEVENS R M, EDWARDS J R, RICHARDS C L Jr, et al. Es- timating health care- associated infections and deaths in U. S. hospitals [ J ]. Public Health Rep, 2007, 122 (2) : 160 - 166.
  • 2Drissi M, Ahmed ZB, Dehecq B, et al. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of pseud- omonas aeruginosa: First report inAlgeria[J]. Med Mal Infect ,2008, 38(4): 187.
  • 3Rubin J. Walker RD, Bliekenstaff K, et al. Antimierobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections[ J]. Vet Microbiol, 2008,31(1): 164.
  • 4Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species [J]. Clin Infect Dis, 2006,43(Suppl. 2) :$95 -$99.
  • 5BqrtlettJG.感染性疾病的诊断与治疗[M].2版.马小军,译.北京:科学技术文献出版社,2012:377-379.
  • 6Hu Y, Li L, Li W, et al. Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta - analysis of retrospective and prospective studies[J], lnt JAntimicrob Agents, 2013,42:492 - 496.
  • 7Akova M, Daikos GL, Tzouvelekis L, et al. Interventional strategies and current clinical experience with carbapenemase - producing Gram - negative bacteriaclinical[ J]. Clin Microbiol Infect, 2012,18 : 439 - 480.
  • 8Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing:twenty-Fourth Information SuppIement[S].2014,M100-S24.
  • 9BARBIER F,ANDREMONT A,WOLFF M,et al.Hospital- acquired pneumonia and ventilator-associated pneumonia:recent advances in epidemiology and management[J].Curr Opin Pulm Med,2013,19(3):216-228.
  • 10MORRISSEY I,HACKEL M,BADAL R,et al.A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011[J].Pharmaceuticals (Basel),2013,6(11):1335-1346.

共引文献360

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部